Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Non-cash Items (2020 - 2025)

Aligos Therapeutics filings provide 6 years of Non-cash Items readings, the most recent being $55234.0 for Q4 2025.

  • On a quarterly basis, Non-cash Items fell 99.48% to $55234.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $55234.0, a 99.48% decrease, with the full-year FY2025 number at $55234.0, down 67.9% from a year prior.
  • Non-cash Items hit $55234.0 in Q4 2025 for Aligos Therapeutics, down from $398541.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $62.5 million in Q1 2021 to a low of $33000.0 in Q2 2025.
  • Median Non-cash Items over the past 5 years was $3.6 million (2022), compared with a mean of $9.7 million.
  • Biggest five-year swings in Non-cash Items: plummeted 99.82% in 2022 and later surged 3775.37% in 2023.
  • Aligos Therapeutics' Non-cash Items stood at $16.8 million in 2021, then crashed by 77.75% to $3.7 million in 2022, then skyrocketed by 62.19% to $6.0 million in 2023, then skyrocketed by 75.4% to $10.6 million in 2024, then plummeted by 99.48% to $55234.0 in 2025.
  • The last three reported values for Non-cash Items were $55234.0 (Q4 2025), $398541.0 (Q3 2025), and $33000.0 (Q2 2025) per Business Quant data.